• 1
    Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ. Cancer statistics, 2006. CA Cancer J Clin 2006; 56: 10630.
  • 2
    Madigan MP, Ziegler RG, Benichou J, Byrne C, Hoover RN. Proportion of breast cancer cases in the United States explained by well-established risk factors. J Natl Cancer Inst 1995; 87: 16815.
  • 3
    Ron E. Cancer risks from medical radiation. Health Phys 2003; 85: 4759.
  • 4
    Breast Cancer Association C. Commonly studied single-nucleotide polymorphisms and breast cancer: results from the Breast Cancer Association Consortium. J Natl Cancer Inst 2006; 98: 138296.
  • 5
    Garcia-Closas M, Egan KM, Newcomb PA, Brinton LA, Titus-Ernstoff L, Chanock S, Welch R, Lissowska J, Peplonska B, Szeszenia-Dabrowska N, Zatonski W, Bardin-Mikolajczak A, et al. Polymorphisms in DNA double-strand break repair genes and risk of breast cancer: two population-based studies in USA and Poland, and meta-analyses. Hum Genet 2006; 119: 37688.
  • 6
    Zhang Y, Newcomb PA, Egan KM, Titus-Ernstoff L, Chanock S, Welch R, Brinton LA, Lissowska J, Bardin-Mikolajczak A, Peplonska B, Szeszenia-Dabrowska N, Zatonski W, et al. Genetic polymorphisms in base-excision repair pathway genes and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2006; 15: 3538.
  • 7
    Lake SL, Lyon H, Tantisira K, Silverman EK, Weiss ST, Laird NM, Schaid DJ. Estimation and tests of haplotype-environment interaction when linkage phase is ambiguous. Hum Hered 2003; 55: 5665.
  • 8
    Duell EJ, Millikan RC, Pittman GS, Winkel S, Lunn RM, Tse CK, Eaton A, Mohrenweiser HW, Newman B, Bell DA. Polymorphisms in the DNA repair gene XRCC1 and breast cancer. Cancer Epidemiol Biomarkers Prev 2001; 10: 21722.
  • 9
    Figueiredo JC, Knight JA, Briollais L, Andrulis IL, Ozcelik H. Polymorphisms XRCC1-R399Q and XRCC3-T241M and the risk of breast cancer at the Ontario site of the breast cancer family registry. Cancer Epidemiol Biomarkers Prev 2004; 13: 58391.
  • 10
    Millikan RC, Player JS, Decotret AR, Tse CK, Keku T. Polymorphisms in DNA repair genes, medical exposure to ionizing radiation, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2005; 14: 232634.
  • 11
    Spurdle AB, Hopper JL, Chen X, McCredie MR, Giles GG, Newman B, Chenevix-Trench G, Khanna K. No evidence for association of ataxia-telangiectasia mutated gene T2119C and C3161G amino acid substitution variants with risk of breast cancer. Breast Cancer Res 2002; 4: R15.
  • 12
    Hall EJ, Giaccia AJ. Radiobiology for the radiologist, 6th edn. Philadelphia: Lippincott Williams & Wilkins, 2006.
  • 13
    Sigurdson AJ, Doody MM, Rao RS, Freedman DM, Alexander BH, Hauptmann M, Mohan AK, Yoshinaga S, Hill DA, Tarone R, Mabuchi K, Ron E, et al. Cancer incidence in the US radiologic technologists health study, 1983–1998. Cancer. 2003; 97: 30809.
  • 14
    Bhatti P, Church DM, Rutter JL, Struewing JP, Sigurdson AJ. Candidate single nucleotide polymorphism selection using publicly available tools: a guide for epidemiologists. Am J Epidemiol 2006; 164: 794804.
  • 15
    Carlson CS, Eberle MA, Rieder MJ, Smith JD, Kruglyak L, Nickerson DA. Additional SNPs and linkage-disequilibrium analyses are necessary for whole-genome association studies in humans. Nat Genet 2003; 33: 51821.
  • 16
    Stredrick DL, Garcia-Closas M, Pineda MA, Bhatti P, Alexander BH, Doody MM, Lissowska J, Peplonska B, Brinton LA, Chanock SJ, Struewing JP, Sigurdson AJ. The ATM missense mutation p.Ser49Cys (c.146C > G) and the risk of breast cancer. Hum Mutat 2006; 27: 53844.
  • 17
    Packer BR, Yeager M, Staats B, Welch R, Crenshaw A, Kiley M, Eckert A, Beerman M, Miller E, Bergen A, Rothman N, Strausberg R, et al. SNP500Cancer: a public resource for sequence validation and assay development for genetic variation in candidate genes. Nucleic Acids Res 2004; 32: D528D32. Database issue.
  • 18
    Simon SL, Weinstock RM, Doody MM, Neton J, Wenzl T, Stewart P, Mohan AK, Yoder RC, Hauptmann M, Freedman DM, Cardarelli J, Feng HA, et al. Estimating historical radiation doses to a cohort of U.S. radiologic technologists. Radiat Res 2006; 166: 17492.
  • 19
    Bhatti P, Preston DL, Doody MM, Hauptmann M, Kampa D, Alexander BH, Petibone D, Simon SL, Weinstock RM, Bouville A, Yong LC, Freedman DM, et al. Retrospective biodosimetry among United States radiologic technologists. Radiat Res 2007; 167: 72734.
  • 20
    National Research Council, Committee on the Biological Effects of Ionizing Radiations. BEIR VII: health risks from exposure to low levels of ionizing radiation, Washington D.C.: National Academies Press 1990.
  • 21
    United Nations Scientific Committee on the Effects of Atomic Radiation. Sources and effects of ionizing radiation: UNSCEAR 2000 report to the General Assembly, with scientific annexes, United Nations, 2000.
  • 22
    Land CE. Temporal distributions of risk for radiation-induced cancers. J Chronic Dis 1987; 40( Suppl. 2): 45S57S.
  • 23
    Betsou S, Efstathopoulos EP, Katritsis D, Faulkner K, Panayiotakis G. Patient radiation doses during cardiac catheterization procedures. Br J Radiol 1998; 71: 6349.
  • 24
    Kereiakes JG, Rosenstein M. Handbook of radiation doses in nuclear medicine and diagnostic X-rayed. Boca Raton, Florida: CRC, 1980.
  • 25
    Shapiro S, Strax P, Venet L. Evaluation of periodic breast cancer screening with mammography. Methodology and early observations. JAMA 1966; 195: 7318.
  • 26
    Boice JD,Jr, Morin MM, Glass AG, Friedman GD, Stovall M, Hoover RN, Fraumeni JF,Jr. Diagnostic X-ray procedures and risk of leukemia, lymphoma, and multiple myeloma. JAMA 1991; 265: 12904.
  • 27
    Preston DL, Mattsson A, Holmberg E, Shore R, Hildreth NG, Boice JD,Jr. Radiation effects on breast cancer risk: a pooled analysis of eight cohorts. Radiat Res 2002; 158: 22035.
  • 28
    Angele S, Romestaing P, Moullan N, Vuillaume M, Chapot B, Friesen M, Jongmans W, Cox DG, Pisani P, Gerard JP, Hall J. ATM haplotypes and cellular response to DNA damage: association with breast cancer risk and clinical radiosensitivity. Cancer Res 2003; 63: 871725.
  • 29
    Mohrenweiser HW, Wilson DM,III, Jones IM. Challenges and complexities in estimating both the functional impact and the disease risk associated with the extensive genetic variation in human DNA repair genes. Mutat Res 2003; 526: 93125.
  • 30
    Land CE, Tokunaga M, Koyama K, Soda M, Preston DL, Nishimori I, Tokuoka S. Incidence of female breast cancer among atomic bomb survivors, Hiroshima and Nagasaki, 1950–1990. Radiat Res 2003; 160: 70717.
  • 31
    Thompson LH, Schild D. Recombinational DNA repair and human disease. Mutat Res 2002; 509: 4978.
  • 32
    Kashino G, Kodama S, Suzuki K, Matsumoto T, Watanabe M. Exogenous expression of exonuclease domain-deleted WRN interferes with the repair of radiation-induced DNA damages. J Radiat Res (Tokyo) 2005; 46: 40714.
  • 33
    Baeyens A, Thierens H, Claes K, Poppe B, de Ridder L, Vral A. Chromosomal radiosensitivity in BRCA1 and BRCA2 mutation carriers. Int J Radiat Biol 2004; 80: 74556.
  • 34
    Ponnaiya B, Cornforth MN, Ullrich RL. Induction of chromosomal instability in human mammary cells by neutrons and gamma rays. Radiat Res 1997; 147: 28894.
  • 35
    Ullrich RL, Ponnaiya B. Radiation-induced instability and its relation to radiation carcinogenesis. Int J Radiat Biol 1998; 74: 74754.
  • 36
    Bhatti P, Sigurdson AJ, Wang SS, Chen J, Rothman N, Hartge P, Bergen AW, Landi MT. Genetic variation and willingness to participate in epidemiologic research: data from three studies. Cancer Epidemiol Biomarkers Prev 2005; 14: 244953.
  • 37
    Radiation Effects Research Foundation Department of Statistics. Effect of AHS participation on cancer survival. Radiat Effects Res Found News Views 2002; 13: 28.